MyFinsight
Home
About
Contact
vrca: the income statement
Download
Download image
License And
Collaboration Revenue
$10,737K
Product
$3,607K
Total revenue
$14,344K
(905.39%↑ Y/Y)
Net loss
-$274K
(98.80%↑ Y/Y)
Income (loss) from
operations
$1,627K
(107.86%↑ Y/Y)
Total operating
expenses
$12,717K
(-32.80%↓ Y/Y)
Total other expense,
net
-$1,901K
(11.83%↑ Y/Y)
Change in fair value of
derivative liability
$34K
Interest income
$159K
(-28.05%↓ Y/Y)
Research and development
$2,205K
(-8.32%↓ Y/Y)
Selling, general and
administrative
$9,403K
(-41.53%↓ Y/Y)
Cost of
collaboration revenue
$355K
(322.62%↑ Y/Y)
Cost of product
revenue
$754K
(114.81%↑ Y/Y)
Interest expense
$2,094K
(-11.87%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)